RXD vs. FTXH
RXD (ProShares UltraShort Health Care) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both exchange-traded funds - RXD is a Leveraged Equities fund tracking the DJ Global United States (All) / Health Care -IND (-200%), while FTXH is a Health & Biotech Equities fund tracking the Nasdaq U.S. Smart Pharmaceuticals Index. Both are passively managed. Over the past 5 years, RXD returned -7.55%/yr vs 8.84%/yr for FTXH. At a correlation of -0.71, they often move in opposite directions. RXD charges 0.95%/yr vs 0.60%/yr for FTXH.
Performance
RXD vs. FTXH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXD achieves a -1.40% return, which is significantly lower than FTXH's 13.18% return.
RXD
- 1D
- -3.08%
- 1M
- -9.66%
- YTD
- -1.40%
- 6M
- 0.04%
- 1Y
- -25.85%
- 3Y*
- -8.16%
- 5Y*
- -7.55%
- 10Y*
- -20.50%
FTXH
- 1D
- 1.20%
- 1M
- 7.35%
- YTD
- 13.18%
- 6M
- 11.16%
- 1Y
- 46.87%
- 3Y*
- 14.15%
- 5Y*
- 8.84%
- 10Y*
- —
RXD vs. FTXH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | -1.40% | -21.66% | 4.83% | 3.25% | 1.20% | -37.97% | -44.25% | -32.44% | -14.33% | -35.24% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 13.18% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
Correlation
The correlation between RXD and FTXH is -0.85, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.85 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.83 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.82 |
Correlation (All Time) Calculated using the full available price history since Sep 22, 2016 | -0.71 |
The correlation between RXD and FTXH shifts across timeframes, from -0.85 (1 year) to -0.71 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXD vs. FTXH — Risk / Return Rank
RXD
FTXH
RXD vs. FTXH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RXD | FTXH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.59 | ||
| Sortino ratioReturn per unit of downside risk | -5.05 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.46 | -0.59 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 6.30 | -7.05 |
| Martin ratioReturn relative to average drawdown | -1.12 | 18.56 | -19.68 |
Loading charts...
Drawdowns
RXD vs. FTXH - Drawdown Comparison
The maximum RXD drawdown since its inception was -99.65%, which is greater than FTXH's maximum drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for RXD and FTXH.
Loading charts...
Drawdown Indicators
| RXD | FTXH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.65% | -32.11% | -67.54% |
Max Drawdown (1Y)Largest decline over 1 year | -34.63% | -7.47% | -27.16% |
Max Drawdown (3Y)Largest decline over 3 years | -36.60% | -19.51% | -17.09% |
Max Drawdown (5Y)Largest decline over 5 years | -40.50% | -19.51% | -20.99% |
Max Drawdown (10Y)Largest decline over 10 years | -90.64% | — | — |
Current DrawdownCurrent decline from peak | -99.63% | 0.00% | -99.63% |
Average DrawdownAverage peak-to-trough decline | -81.91% | -5.80% | -76.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.10% | 2.53% | +20.57% |
Volatility
RXD vs. FTXH - Volatility Comparison
ProShares UltraShort Health Care (RXD) has a higher volatility of 10.55% compared to First Trust Nasdaq Pharmaceuticals ETF (FTXH) at 5.48%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than FTXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXD | FTXH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.55% | 5.48% | +5.07% |
Volatility (6M)Calculated over the trailing 6-month period | 21.92% | 12.01% | +9.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.33% | 17.22% | +13.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.91% | 16.38% | +13.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.01% | 18.42% | +14.59% |
RXD vs. FTXH - Expense Ratio Comparison
RXD has a 0.95% expense ratio, which is higher than FTXH's 0.60% expense ratio.
Dividends
RXD vs. FTXH - Dividend Comparison
RXD's dividend yield for the trailing twelve months is around 3.01%, more than FTXH's 1.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.38% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% |
RXD ProShares UltraShort Health Care | 3.01% | 3.29% | 4.36% | 3.17% | 0.67% | 0.00% | 0.17% | 1.73% | 0.22% | 0.00% | 0.00% |
Frequently Asked Questions
RXD and FTXH have a correlation of -0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXD has higher volatility (10.55%) compared to FTXH (5.48%). In terms of maximum drawdown, RXD dropped -99.65% vs FTXH's -32.11%.
On 5-year performance, FTXH leads with 8.84% vs -7.55% for RXD. On fees, FTXH is cheaper at 0.60% per year. On volatility, FTXH has been the lower-risk option at 5.48%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FTXH has performed better with a 8.84% return vs -7.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FTXH is cheaper with a 0.60% expense ratio, compared with 0.95% for RXD.
RXD has the higher dividend yield at 3.01%, compared with 1.38% for FTXH.
RXD is categorized as Leveraged Equities, while FTXH is Health & Biotech Equities. RXD tracks DJ Global United States (All) / Health Care -IND (-200%), while FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index. They also come from different issuers: ProShares and First Trust. Their fees differ too: 0.95% for RXD and 0.60% for FTXH.
FTXH currently has the higher Sharpe Ratio (2.74 vs -0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXD and FTXH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer